返回
Turn Therapeutics Inc（TTRX）價格
TTRX 股價走勢圖
TTRX 財務
Turn Therapeutics Inc
$4.56
-5.39%
$-0.26
收盤價：Jan 16, 16:00:00 GMT-5
$4.54
-0.43%
$-0.01
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$4.82
開盤價
$4.85
當日範圍
$4.54 - $4.85
52週區間
$2.57 - $26.5
交易量
28.5K
平均成交量
91.1K
每股盈餘 (TTM)
--
股息收益率
--
市值
$133.7M
什麼是 TTRX？
Turn Therapeutics, Inc. focuses on solving massive health problems by eliminating diseases and strengthening health systems through powerful partnerships and operational research. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
